Literature DB >> 11083084

Diphenyl diselenide and diphenyl ditelluride differentially affect delta-aminolevulinate dehydratase from liver, kidney, and brain of mice.

E N Maciel1, R C Bolzan, A L Braga, J B Rocha.   

Abstract

In the present study, the inhibitory effect of diphenyl diselenide and diphenyl ditelluride after in vitro, acute (a single dose), or chronic exposure (14 doses) was examined in mice 24 hours after the last administration. In vitro, diphenyl diselenide, and diphenyl ditelluride inhibited delta-aminolevulinate dehydratase (delta-ALA-D) from brain, liver, and kidney with a similar potency (IC50 5-10 microM), and at 120 microM, they increased the rate of dithiothreitol (DTT) and reduced glutathione (GSH) oxidation. After a single dose (sc), diphenyl diselenide (1 mmol/kg) inhibited the liver (22%, p < 0.01) and brain (27%, p < 0.01) delta-ALA-D, but it did not inhibit the kidney enzyme. After a single dose (sc), diphenyl ditelluride (0.5 mmol/kg) inhibited liver (46%, p < 0.01), kidney (21%, p < 0.05), and brain (39%, p < 0.01) delta-ALA-D. Chronic exposure to diphenyl diselenide (0.125 and 0.250 mmol/kg) caused significant (p < 0.05) increase in liver and liver-to-body weight ratio and inhibited liver (40 and 60%, respectively) and brain (21 and 40%, respectively) delta-ALA-D. Kidney delta-ALA-D was not inhibited significantly after exposure to diphenyl diselenide. Total nonprotein - SH concentration was decreased only in liver of animals exposed for 14 days to selenide. Chronic exposure to diphenyl ditelluride (0.010 and 0.025 mmol/kg) caused significant (p < 0.05) inhibition of liver (28 and 42%, respectively) and brain (23 and 54%, respectively) delta-ALA-D. Kidney delta-ALA-D was not inhibited significantly by diphenyl ditelluride. Total nonprotein--SH concentration was decreased to a different extent after acute or chronic treatment with diphenyl ditelluride depending on analyzed tissue. Hemoglobin content was decreased significantly by 17 and 22% after chronic treatment with 0.125 and 0.25 mmol/kg diphenyl diselenide, respectively. Chronic exposure to 0.010 mmol/kg diphenyl ditelluride caused a reduction of 17% in hemoglobin content that tended to be significant (p < 0.10). These results suggest that delta-ALA-D inhibition after exposure to organochalcogens may perturb heme-dependent metabolic pathway and contribute to the toxicological properties of these compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083084     DOI: 10.1002/1099-0461(2000)14:6<310::AID-JBT3>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  16 in total

1.  Diphenyl diselenide and diphenyl ditelluride: neurotoxic effect in brain of young rats, in vitro.

Authors:  Ana Cristina Guerra Souza; Eluza Curte Stangherlin; Ana Paula Ardais; Cristina Wayne Nogueira
Journal:  Mol Cell Biochem       Date:  2010-02-24       Impact factor: 3.396

2.  The organochalcogen 3-methyl-1-phenyl-2-(phenylseleno)oct-2-en-1-one induces oxidative stress in heart, liver, and kidney of rats.

Authors:  Tanise Gemelli; Carlos Augusto Souza Carvalho; Rodrigo Binkowski de Andrade; Robson Brum Guerra; Lívia Oliboni; Mirian Salvador; Caroline Dani; Cláudia Funchal
Journal:  Mol Cell Biochem       Date:  2011-05-01       Impact factor: 3.396

3.  Antioxidant properties of new chalcogenides against lipid peroxidation in rat brain.

Authors:  J I Rossato; L A Ketzer; F B Centurião; S J N Silva; D S Lüdtke; G Zeni; A L Braga; M A Rubin; J B T Rocha
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

4.  Exposure to ebselen changes glutamate uptake and release by rat brain synaptosomes.

Authors:  Cristina W Nogueira; Liane N Rotta; Gilson Zeni; Diogo O Souza; João B T Rocha
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

5.  Cooperation of non-effective concentration of glutamatergic system modulators and antioxidant against oxidative stress induced by quinolinic acid.

Authors:  Fernando Dobrachinski; Luiza Lena Bastos; Jessika Cristina Bridi; Cristiane Lenz Dalla Corte; Daiana Silva de Ávila; João Batista Teixeira da Rocha; Félix Alexandre Antunes Soares
Journal:  Neurochem Res       Date:  2012-06-07       Impact factor: 3.996

6.  Comparative studies on dicholesteroyl diselenide and diphenyl diselenide as antioxidant agents and their effect on the activities of Na+/K+ ATPase and delta-aminolevulinic acid dehydratase in the rat brain.

Authors:  Ige J Kade; Marcio W Paixão; Oscar E D Rodrigues; Nilda B V Barbosa; Antonio L Braga; Daiana S Avila; Cristina W Nogueira; João B T Rocha
Journal:  Neurochem Res       Date:  2007-08-21       Impact factor: 3.996

7.  Organochalcogens inhibit mitochondrial complexes I and II in rat brain: possible implications for neurotoxicity.

Authors:  Robson Luiz Puntel; Daniel Henrique Roos; Rodrigo Lopes Seeger; Michael Aschner; João Batista Teixeira Rocha
Journal:  Neurotox Res       Date:  2012-12-06       Impact factor: 3.911

8.  Diphenyl ditelluride targets brain selenoproteins in vivo: inhibition of cerebral thioredoxin reductase and glutathione peroxidase in mice after acute exposure.

Authors:  Bruna Comparsi; Daiane F Meinerz; Jeferson L Franco; Thaís Posser; Alessandro de Souza Prestes; Sílvio Terra Stefanello; Danúbia B dos Santos; Caroline Wagner; Marcelo Farina; Michael Aschner; Alcir L Dafre; João B T Rocha
Journal:  Mol Cell Biochem       Date:  2012-08-12       Impact factor: 3.396

9.  Organochalcogens affect the glutamatergic neurotransmission in human platelets.

Authors:  V C Borges; C W Nogueira; G Zeni; J B T Rocha
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

10.  Effect of in vitro exposure of human serum to 3-butyl-1-phenyl-2-(phenyltelluro)oct-en-1-one on oxidative stress.

Authors:  Carlos Augusto Souza Carvalho; Tanise Gemelli; Robson Brum Guerra; Lívia Oliboni; Mirian Salvador; Caroline Dani; Alex Sander Araújo; Marcello Mascarenhas; Cláudia Funchal
Journal:  Mol Cell Biochem       Date:  2009-06-25       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.